Company Description
Corgi Data & Surveillance ETF (BATS: EYES) is a publicly traded surgical and medical instrument manufacturing company in the Electromedical & Electrotherapeutic Apparatus sector.
EYES stock has gained 11.1% over the past year. Shares last traded at $28.03.
On a trailing twelve-month basis, Corgi Data & Surveillance ETF reported revenue of $0 with net income of $26.6M and diluted earnings per share of $-0.43.
This page provides a comprehensive overview of EYES stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Corgi Data & Surveillance ETF (EYES) stock last traded at $28.03, up 2.87% from the previous close. Over the past 12 months, the stock has gained 11.1%.
EYES Rankings
Latest News
Corgi Data & Surveillance ETF has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 7 with negative movement. Key topics include acquisition, offering. View all EYES news →
SEC Filings
Financial Highlights
operating income reached -$27.6M, and net income was $26.6M. Diluted earnings per share stood at $-0.43. The company generated -$24.3M in operating cash flow. With a current ratio of 2.71, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Days to Cover History
EYES Company Profile & Sector Positioning
Corgi Data & Surveillance ETF (EYES) operates in the Surgical and Medical Instrument Manufacturing industry within the broader Electromedical & Electrotherapeutic Apparatus sector and is listed on the BATS.